SANGE CONSULT ApS: Financial statements 2025
CVR: 43520989
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
SANGE CONSULT ApS (CVR 43520989) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -16,928 and a net result of DKK -17,272 compared with DKK -55,849 the year before. Equity in the 2025 report amounted to DKK -79,956.
- Gross Profit
- DKK -16,928
- Profit/Loss
- DKK -17,272
- Equity
- DKK -79,956
- Total Assets
- DKK 103,704
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -17 t. | -17 t. | -80 t. | 0 |
| 2024 | - | -55 t. | -56 t. | -63 t. | 0 |
Official annual report
How creditworthy is SANGE CONSULT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
SANGE CONSULT ApS has published its annual report for 2024. Gross profit came to DKK -55,346, and the net result was DKK -55,849.
About SANGE CONSULT ApS
SANGE CONSULT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2022. The company is registered under the industry Andre forretningsserviceaktiviteter i.a.n.. The company was previously named SANGE TRADING ApS. The management consists of Sangevan Sayananthan. The company is owned by SANGE CAPITAL ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -16,928 and a net result of DKK -17,272 compared with DKK -55,849 the year before. Equity in the 2025 report amounted to DKK -79,956.